Literature DB >> 16940297

Interactions between merozoite surface proteins 1, 6, and 7 of the malaria parasite Plasmodium falciparum.

Christian W Kauth1, Ute Woehlbier, Michaela Kern, Zeleke Mekonnen, Rolf Lutz, Norbert Mücke, Jörg Langowski, Hermann Bujard.   

Abstract

Merozoites of the malaria parasite Plasmodium falciparum expose at their surface a large multiprotein complex, composed of proteolytically processed, noncovalently associated products of at least three genes, msp-1, msp-6, and msp-7. During invasion of erythrocytes, this complex is shed from the surface except for a small glycosylphosphatidylinositol-anchored portion originating from MSP-1. The proteolytic cleavage separating the C-terminal portion of MSP-1 is required for successful invasion. Little is known about the structure and function of the abundant and essential multipartite complex. Using heterologously produced MSP-1, MSP-6, and MSP-7 in precursor and with the exception of MSP-7 in processed form, we have studied in vitro the complex formation between the different proteins to identify the interaction partners within the complex. Both MSP-6(36) and MSP-7 bind only to MSP-1 subunits that are shed, but although MSP-6(36) contacts just subunit p38, MSP-7 interacts with p83, p30, and p38. The intact C-terminal region of MSP-6 is required for the association with p38 as well as for its multimerization into tetramers. Furthermore, our data suggest that only the processed form and not the precursor form of MSP-1 interacts with MSP-6(36). MSP-6- as well as MSP-7-specific rabbit antibodies inhibit parasite multiplication in vitro as shown previously for antibodies directed against MSP-1. Our findings raise interesting questions with regard to proteolysis-mediated mechanisms of maturation of the MSP-1-MSP-6-MSP-7 complex and to the mode by which antibodies directed against this complex interfere with parasite multiplication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940297     DOI: 10.1074/jbc.M604641200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Global identification of multiple substrates for Plasmodium falciparum SUB1, an essential malarial processing protease.

Authors:  Natalie C Silmon de Monerri; Helen R Flynn; Marta G Campos; Fiona Hackett; Konstantinos Koussis; Chrislaine Withers-Martinez; J Mark Skehel; Michael J Blackman
Journal:  Infect Immun       Date:  2011-01-10       Impact factor: 3.441

2.  Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial.

Authors:  Antje Blank; Kristin Fürle; Anja Jäschke; Michael Lanzer; Walter E Haefeli; Hermann Bujard; Gerd Mikus; Monika Lehmann; Johannes Hüsing; Kirsten Heiss; Thomas Giese; Darrick Carter; Ernst Böhnlein
Journal:  NPJ Vaccines       Date:  2020-01-31       Impact factor: 7.344

3.  Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.

Authors:  Anja Jäschke; Boubacar Coulibaly; Edmond J Remarque; Hermann Bujard; Christian Epp
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

4.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

5.  Insights into Duffy binding-like domains through the crystal structure and function of the merozoite surface protein MSPDBL2 from Plasmodium falciparum.

Authors:  Anthony N Hodder; Peter E Czabotar; Alessandro D Uboldi; Oliver B Clarke; Clara S Lin; Julie Healer; Brian J Smith; Alan F Cowman
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

6.  Limited variation in vaccine candidate Plasmodium falciparum Merozoite Surface Protein-6 over multiple transmission seasons.

Authors:  Aaron T Neal; Stephen J Jordan; Ana L Oliveira; Jean N Hernandez; Oralee H Branch; Julian C Rayner
Journal:  Malar J       Date:  2010-05-24       Impact factor: 2.979

7.  Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.

Authors:  Ute Woehlbier; Christian Epp; Fiona Hackett; Michael J Blackman; Hermann Bujard
Journal:  Malar J       Date:  2010-03-18       Impact factor: 2.979

8.  Regulated maturation of malaria merozoite surface protein-1 is essential for parasite growth.

Authors:  Matthew A Child; Christian Epp; Hermann Bujard; Michael J Blackman
Journal:  Mol Microbiol       Date:  2010-02-08       Impact factor: 3.501

9.  Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development.

Authors:  Jack S Richards; Thangavelu U Arumugam; Linda Reiling; Julie Healer; Anthony N Hodder; Freya J I Fowkes; Nadia Cross; Christine Langer; Satoru Takeo; Alex D Uboldi; Jennifer K Thompson; Paul R Gilson; Ross L Coppel; Peter M Siba; Christopher L King; Motomi Torii; Chetan E Chitnis; David L Narum; Ivo Mueller; Brendan S Crabb; Alan F Cowman; Takafumi Tsuboi; James G Beeson
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

10.  Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.

Authors:  Arunaditya Deshmukh; Bishwanath Kumar Chourasia; Sonali Mehrotra; Ikhlaq Hussain Kana; Gourab Paul; Ashutosh Panda; Inderjeet Kaur; Susheel Kumar Singh; Sumit Rathore; Aparup Das; Priya Gupta; Md Kalamuddin; S K Gakhar; Asif Mohmmed; Michael Theisen; Pawan Malhotra
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.